Category: Press Release - Page 21 - Psychedelic Alpha

Read more about the article Psyence Group Announces Closing of Fourth Tranche of Private Placement and Conversion of Convertible Debt Note

Psyence Group Announces Closing of Fourth Tranche of Private Placement and Conversion of Convertible Debt Note

Post published:April 3, 2023
Post category:Press Release

Read more about the article Algernon NeuroScience Announces U.S. SEC Qualification of Regulation A+ Tier II Offering to Raise up to USD $10M

Algernon NeuroScience Announces U.S. SEC Qualification of Regulation A+ Tier II Offering to Raise up to USD $10M

Post published:April 3, 2023
Post category:Press Release

Read more about the article Reunion Neuroscience Appoints Dr. Fred Grossman to Board of Directors

Reunion Neuroscience Appoints Dr. Fred Grossman to Board of Directors

Post published:April 3, 2023
Post category:Press Release

Read more about the article Revive Therapeutics Advances MDMA Transdermal Patch Development with Purchase of MDMA Supply from PharmAla Biotech

Revive Therapeutics Advances MDMA Transdermal Patch Development with Purchase of MDMA Supply from PharmAla Biotech

Post published:April 3, 2023
Post category:Press Release

Read more about the article Mindset Pharma to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023

Mindset Pharma to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023

Post published:April 3, 2023
Post category:Press Release

Read more about the article FILAMENT HEALTH REPORTS Q4 AND YEAR END 2022 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

FILAMENT HEALTH REPORTS Q4 AND YEAR END 2022 FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

Post published:April 1, 2023
Post category:Press Release

Read more about the article Numinus to Host Q2 2023 Results Conference Call on April 13, 2023

Numinus to Host Q2 2023 Results Conference Call on April 13, 2023

Post published:March 30, 2023
Post category:Press Release

Read more about the article Apex Labs Meets Endpoints in First-of-its-Kind Take Home Microdose Psilocybin Clinical Trial

Apex Labs Meets Endpoints in First-of-its-Kind Take Home Microdose Psilocybin Clinical Trial

Post published:March 29, 2023
Post category:Press Release

Read more about the article PharmaTher Holdings Announces Update of Type C Meeting with the FDA for KETARX™ (Ketamine) in Parkinson’s Disease

PharmaTher Holdings Announces Update of Type C Meeting with the FDA for KETARX™ (Ketamine) in Parkinson’s Disease

Post published:March 29, 2023
Post category:Press Release

Read more about the article BetterLife’s Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Drug Discovery & Development Article

BetterLife’s Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Drug Discovery & Development Article

Post published:March 29, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.